Literature DB >> 12814204

Trends in the incidence of ocular melanoma in the United States, 1974-1998.

Peter D Inskip1, Susan S Devesa, Joseph F Fraumeni.   

Abstract

BACKGROUND: A recent report noted a fourfold risk of ocular melanoma associated with employment in occupations involving use of cellular telephones.
METHODS: To aid interpretation of this finding, and clarify how subsite-specific temporal variation in incidence of ocular melanoma compares with that for cutaneous melanoma, we examined time trends in the incidence of melanoma among whites in the United States, based on data collected through the surveillance, Epidemiology, and End Results (SEER) program for 1974-1998.
RESULTS: The incidence of ocular melanoma decreased over time in both sexes, with no indication of a recent increase during the 1990s. The annual percent change was -0.7% for males (95% confidence interval: -2.3, 0.9) and -1.2% for females (95% confidence interval: -2.5, 0.0). Time trends appeared to differ by subsite of ocular melanoma; rates were flat for the choroid, decreased for the ciliary body, and increased for the conjunctiva (among males only) beginning in the 1980s. In contrast, all subsites of cutaneous melanoma, including the face and adjacent areas, showed marked increases in incidence over the observation period.
CONCLUSIONS: The dramatic increase in use of cellular telephones has not been accompanied by an increase in the incidence of ocular melanoma. Further study is required to explain the different time trends for subsites of ocular melanoma, and for ocular versus facial and other cutaneous melanomas.

Entities:  

Mesh:

Year:  2003        PMID: 12814204     DOI: 10.1023/a:1023684502638

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  11 in total

1.  Intra-ocular melanoma metastatic to an axillary lymph node: a case report.

Authors:  Nirupama Anne; Ratnakishore Pallapothu
Journal:  World J Surg Oncol       Date:  2011-05-27       Impact factor: 2.754

Review 2.  Conjunctival Melanoma - Epidemiological Trends and Features.

Authors:  Snježana Kaštelan; Antonela Gverović Antunica; Lidija Beketić Orešković; Jasminka Salopek Rabatić; Boris Kasun; Ivana Bakija
Journal:  Pathol Oncol Res       Date:  2018-05-25       Impact factor: 3.201

3.  Episcleral plaque brachytherapy using 'BARC I-125 Ocu-Prosta seeds' in the treatment of intraocular tumors: a single-institution experience in India.

Authors:  Parag K Shah; V Narendran; U Selvaraj; P Guhan; Sanjay K Saxena; Ashutosh Dash; Melvin Astrahan
Journal:  Indian J Ophthalmol       Date:  2012-07       Impact factor: 1.848

4.  Therapeutic efficacy by targeting correction of Notch1-induced aberrants in uveal tumors.

Authors:  Xiaolin Huang; Li Wang; He Zhang; Haibo Wang; Xiaoping Zhao; Guanxiang Qian; Jifan Hu; Shengfang Ge; Xianqun Fan
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

5.  Resistance of uveal melanoma to the interstrand cross-linking agent mitomycin C is associated with reduced expression of CYP450R.

Authors:  P Gravells; L Hoh; D Canovas; I G Rennie; K Sisley; H E Bryant
Journal:  Br J Cancer       Date:  2011-03-08       Impact factor: 7.640

6.  Exceptional response and multisystem autoimmune-like toxicities associated with the same T cell clone in a patient with uveal melanoma treated with immune checkpoint inhibitors.

Authors:  Suthee Rapisuwon; Benjamin Izar; Cory Batenchuk; Alexandre Avila; Shaolin Mei; Peter Sorger; Jerry M Parks; Sarah J Cooper; David Wagner; Jay C Zeck; Aline J Charabaty; Michael B Atkins
Journal:  J Immunother Cancer       Date:  2019-03-04       Impact factor: 13.751

7.  Mobile phone use and risk of uveal melanoma: results of the risk factors for uveal melanoma case-control study.

Authors:  Andreas Stang; Andrea Schmidt-Pokrzywniak; Timothy L Lash; Peter Karl Lommatzsch; Gerhard Taubert; Norbert Bornfeld; Karl-Heinz Jöckel
Journal:  J Natl Cancer Inst       Date:  2009-01-13       Impact factor: 13.506

8.  Solitary secondary malignant melanoma of clavicle two years after enuclation for ocular melanoma.

Authors:  Halil Tozum; Korhan Ozkan; Krishna Reddy; Ismail Turkmen; Ufuk Ciloglu; Serkan Senol; Calogero Graci
Journal:  Case Rep Orthop       Date:  2013-01-28

9.  Conjunctival melanoma: a review of conceptual and treatment advances.

Authors:  Li-Anne Lim; Michele C Madigan; R Max Conway
Journal:  Clin Ophthalmol       Date:  2013-03-13

10.  Choroidal melanoma metastasizing to maxillofacial bones.

Authors:  Manoj Pandey; Om Prakash; Anitha Mathews; Nileena Nayak; Krishnankutty Ramachandran
Journal:  World J Surg Oncol       Date:  2007-03-08       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.